European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Development of a synbiotic potential score as a quantitative approach for selecting putative synergistic strain-prebiotic candidates June 17, 2026 Study Evaluates Impact of Administration of Oral Serum-Derived Bovine Immunoglobulin on Dysbiosis January 13, 2025 The ‘old friends’ in your gut and how to care for them July 14, 2017
Development of a synbiotic potential score as a quantitative approach for selecting putative synergistic strain-prebiotic candidates June 17, 2026
Study Evaluates Impact of Administration of Oral Serum-Derived Bovine Immunoglobulin on Dysbiosis January 13, 2025